IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge

Time: 11:45 am
day: Day 2 CLINICAL AM


  • An overview of IgG cleaving enzymes: their MOA and translatability for use in conjunction with gene therapies
  • Discussing clinical data from non-gene therapy indications
  • Considerations for treatment timing and dosing of gene therapy post-administration of enzyme